Clinical trial
A Pilot Feasibility Study of Definitive Concurrent Chemoradiation With Pencil Beam Scanning Proton Beam in Combination With 5-Fluorouracil and Mitomycin-C for Carcinoma of the Anal Canal
NCT01858025 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Feasibility Study of Definitive Concurrent Chemoradiation With Pencil Beam Scanning Proton Beam in Combination With 5-Fluorouracil and Mitomycin-C for Carcinoma of the Anal Canal
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- July 31, 2013
- Completion date
- November 30, 2021
- Enrollment
- 25 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
carcinoma of the anal canal